Radiotherapy and Oncology

Article	Citations
The long-term impact of irradiation on functional connectivity in brain circuits involved in memory processes after pediatric posterior fossa tumor	151
The effect of delayed primary treatment initiation on adverse events and recurrence in older head and neck cancer patients	118
OC-0088 Reduced tube feeding dependence by continuous improvements in head and neck radiotherapy	115
Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)	103
Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study	99
PO-1577 Evaluation of a new Automated TLD Reader for silica bead radiotherapy dosimetry	92
Contents	88
Corrigendum to “DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma p	87
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	80
1861: Performance of a heart substructures autocontouring tool after clinical implementation	77
1933: High-resolution Diode array vs film for QA of trigeminal neuralgia treatments with Cyberknife	76
687: Hearing loss after cranial radiation in children: a dosimetry study from the French registry PediaRT	76
3201: Dosimetric properties of flexible 3D-printed boluses	73
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	69
2076: RapidBrachyIVBT: A dosimetry software for personalized image-guided intravascular brachytherapy	67
3050: Impact of a philanthropic online course about cervical cancer on the learning outcome	64
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	64
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	63
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	61
2030: Impact & usability of virtual reality on emotional wellbeing of sarcoma patients:VR-SARC study	61
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT	60
3429: Modulating innate immunity by DNA damage response inhibition	57
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	54
749: Reinforcement learning for accelerated automatic treatment planning optimization	51
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	50

1635: In vivo dosimetry - keeping my finger on the pulse	49
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.	49
204: PET-CT DenseNet outperforms advanced DL models for outcome prediction of oropharyngeal cancer	49
2011: Physical & psychosocial effects of radical chemoradiotherapy for cervix cancer: a systematic review	48
910: Comparison of Eclipse and RayStation in Multi-Criteria Optimization in Prostate Cancer Radiotherapy	48
895: Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer	46
2605: HDR brachytherapy boost plus EBRT in unfavorable prostate cancer: results in more then 700 patients	46
2578: Respiratory gating with CPAP in left breast cancer RT: preliminary results of a prospective study	46
2489: Endothelial senescence primes aggressiveness of glioblastoma cells after radiotherapy	45
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	43
360: The role of SGRT in detecting inter and intra fraction errors in SBRT treatments to the lung	43
2607: Carbon footprint reduction with the adoption of hypofractionation in a public health facility	43
1664: Assessing overall and fractional CTV coverage in breast cancer radiotherapy based on daily imaging	43
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	42
1962: Study protocol B-REST: respiratory und relaxation training in adjuvant radiotherapy of breast cancer	42
1487: Radiotherapy access in the Asia-Pacific: Are we making progress for low- & middle-income countries?	41
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.	41
760: Dependence on the calibration field in treatment verifications using the 1600SRS liquid array	40
1977: PSMA-PET and PCa: an ancillary RADIOSA study beyond a numerical definition of oligometastatic state	40
1586: Dose perturbation due to surgical clips and titanium mesh in proton therapy	40
285: Metal artifact in MR-based synthetic CT for intracranial radiotherapy: impact on dosimetry and setup	40
1006: Prediction of cisplatin tolerance during chemoradiation in older HNSCC patients: A multicenter study	38
2116: Outcomes of EBRT and brachytherapy in anal cancer: retrospective analysis between 2016 and 2021	38
452: Can 1 mm PTV margin be used for radiosurgery patients laying on wedges?	38
2925: Urethral dosimetric implications of a multifocal MRI-based microboost in prostate robotic SBRT	38
3006: Clinical markers of altered Body image in Patients with Head and Neck cancers	37
154: Identifying the Continuous Professional Development Educational Needs of Belgian RTTs	37
2124: Respiratory gated planning of non-small cell lung cancer with new data-driven gated (DDG) PET/CT	36
2010: Postmastectomy radiotherapy after immediate breast reconstruction: toxicities and control rate.	36
2749: Feasibility of SBRT with CK in the scenario of lung metastases re-RT: monoinstitutional experience.	35
3194: LA-NSCLC: clinical outcomes and comparison of 2-weekly versus 4-weekly durvalumab consolidation	35
2026: Quantitative T1 mapping in the presence of an implantable cardiac device on a 1.5T MR-linac	35
1537: Brachytherapy efficacy and safety in the treatment of primitive tongue carcinomas	35
691: A single-arm confirmatory trial of IMRT alone for early-stage oropharyngeal cancer: JCOG1208	34
3346: How to balance the patient and clinician needs: Are we on the same side?	34
1517: Intramedullary and leptomeningeal-epidural metastases. Outcomes of a rare and ominous condition.	34
2353: X-irradiation, but not proton, irradiation, induces an inflammatory cytokine response in saliva	34
2874: Interstitial brachytherapy in carcinoma cervix: long term results, toxicity and patterns of failure	33
1651: The impact of ground-glass opacities on dose calculation accuracy for lung SBRT	33
2974: Generalised Competing Risk models predict relative risk of cancer events in p16+ oropharynx cancer	33
1247: ANTI-TUMOR AND ACUTE TOXICITY OF FRACTIONATED STEREOTACTIC RADIOTHERAPY COMBINED WITH HYPERTHERMIA	33
1136: Electron beam radiotherapy for the management of perianal malignancies	33
512: Proton minibeam radiation therapy: elucidating in vivo mechanisms with infrared microspectroscopy	33
1317: Identifying Lymphocyte Infiltration for Rectal Cancer Outcome Prediction Using Phase III Trial Data	33
3484: RAPTOR project: Verification	33
742: EXTREME HYPOFRACTIONATED RT FOR PROSTATE CA. Phase II. Results in toxicity and economical cost	33
323: A comparison of 3D CNN architectures for monitoring ovarian cancer patients using PET/CT scans	33
3379: Management of older patients with skin cancer: Are we overtreating?	32
3548: Virtual patients for clinical trials	32
1293: Immunotherapy-related hypothyroidism on head and neck cancer: impact of RT dose to the thyroid gland	32

972: Proton therapy for patients with meningioma—Long-term outcomes from ProReg and KiProReg study	31
2019: The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma	31
994: Terminology, Recording, Reporting for Ultra-High Dose Rates: ESTRO Physics of FLASH Workshop update	30
692: T1 & T2 mapping on a Unity MRL in a clinically feasible timeframe	30
1622: Title: Gamma Knife Radiosurgery for Trigeminal Neuralgia: A review of 59 patients	30
OC-0449 Deep learning based NTCP-modelling using 3D-information for predicting late xerostomia	30
Dosimetric analysis of hearing loss after cranial radiation therapy in children: A single-institution study from the French national registry PediaRT	29
Response to the Comment on “Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)” by Baiocchi et al	29
Validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic body radiation	29
MRI and CBCT for lymph node identification and registration in patients with NSCLC undergoing radical radiotherapy	29
A patient-specific auto-planning method for MRI-guided adaptive radiotherapy in prostate cancer	29
Balancing robustness and adaptation rate for proton therapy of lung cancer patients	29
Dosimetric benefit of a library of plans versus single-plan strategy for pre-operative gastric cancer radiotherapy	28
Corrigendum to “Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing” [Radiother. Oncol. 200 (2024) 110477]	28
529 Current standard of care treatment in non-metastatic cervix cancer	28
480 Addressing the education and training needs of RTT in particle radiation therapy	28
292 Correlation of cf DNA with response in head & neck cancer treated with definitive chemoradiotherapy	28
80 Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrence of Hepatocellular Carcinoma After Liver Transplantation	28
Call For Papers: Radiotherapy & Oncology and The Lancet Oncology collaboration	28
44 Ultrahypofractionated Versus Moderately Hypofractionated and Conventionally Fractionated Pelvic Radiotherapy for Prostate Cancer: Outcomes from 3 Prospective Clinical Trials	28
122 Effect of Different Treatment Planning Optimizers on Stereotactic Ablation Radiotherapy (SABR) Volumetric Modulated ARC Therapy (VMAT) Plans	28
23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806)	27
525 Proton and carbon therapy: recent technological advances	27
45 Stereotactic radiosurgery for tremor: a center experience.	27
31 Program Director Perspectives on the Implementation and Experiences of the Competence By Design Curriculum in Canadian Radiation Oncology Training Programs	27
33 An investigator-initiated clinical study using SBRT as “in situ vaccination”:‘R-ISV-FOLactis’trial	27
179 Contralateral Neck Recurrence Following Unilateral Treatment for Oral Tongue Squamous Cell Carcinoma	26
78 Targeting tumor-promoting myeloid cell functions in head & neck cancer	26
PO-1736 Using the DcmCollab Audit Tool to support quality assurance of clinical radiotherapy trials	26
161 14-day Pathway from Decision to Treat to Radiotherapy for Head and Neck Cancer in the National Health Service: An Evaluation of Feasibility and Outcomes at Torbay Hospital.	26
207 ctDNA-based WES enhances actionable alterations detection in locally advanced head and neck cancer	26
123 Can machine-learning model predict overall survival in head and neck cancer patients?	26
PO-1743 Patient positioning and intrafraction movement control protocol using an IGRT and SGRT system in SRS	26
54 Scattered Radiation to the Testis and Testosterone Secretion in Prostate Cancer Treated with Radiotherapy Alone	26
157 Adaptive radiation therapy	26
95 Head and neck cancers with synchronous primary cancers in Ireland	26
PO-1759 Pre-treatment CBCT rotations as a predictor of intra-fraction motion in cranial SRS patients.	26
PH-0496 incidence and pattern of LRR in esophageal cancer patients treated with iCT followed by neoadj CTRT	25
PO-1014 Prognosis classifier for elderly head-and-neck squamous cell carcinoma patients	25
PO-1062 Stereotactic Radiosurgery for Brain Metastases from Renal Cell Carcinoma: A retrospective study	25
PO-1655 Tuning deep learning models for automatic segmentation of head and neck cancers in PET/CT images	25
PO-1617 Assessing the impact of treatment delivery uncertainty using DVHs	25
PO-1016 External validation of a nomogram for chemoirradiation in stage 2 nasopharyngeal carcinoma with IMRT	25
PO-1929 Identification of DNA repair-based biomarkers related to treatment outcome in head and neck cancers	25
PO-1034 Hypofractionated Radiotherapy and Simultaneous Boost in radically inoperable cases with Glioblastoma	25
PO-1077 Population-based study on the association between autoimmune disease and lymphoma in Korea	24
PO-1084 Radiotherapy with simultaneous integrated boost for breast cancer: acute toxicity outcomes	24
SP-0371 Every physicist should also be a fully skilled data scientist	24
PO-1053 cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer	24
PO-1061 Acces to radiation therapy in Lebanon: current status and challenges	24
SP-0014 Does work-place based assessment deliver on its promise?	24
PO-1113 A dosimetric comparison of two external beam radiotherapy techniques: 3DCRT & Tomotherapy in APBI	24
PO-1988 Designing a radiation therapy technologist training program for online adaptive Radiation Therapy	24
PO-1079 Do you use RT as part of bridging therapy for the treatment of DLBCL with CAR-T cells?	24
SP-0011 New developments In skin cancers treatment: is brachytherapy the new frontier especially for the face?	24
SP-0024 Radiotherapy for vestibular schwannoma and meningioma	24
SP-0510 Physicist: Integration of imaging modalities in treatment planning	24
PO-1990 Remote RTT training in an international context during a global pandemic	24
38: Radiation Therapy of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck – Insights from the Analysis of the BC Cancer Registry 2007-2017	23
PO-0944 Correlation on G8 score with sarcopenia is a prognostic factor for OS in patients with HNC	23
PH-0224 Association between the genomic immune response and locoregional control in ER- breast cancer	23
PD-0827 Development of target-optimized CBCT imaging to reduce imaging dose and improve image quality	23
PO-1119 Internal Mammary Irradiation in breast cancer. Do CTV-PTV safety margins matter?	23
PO-1826 A tool to standardize plan quality in moderate hypofractionated prostate radiotherapy	23
PO-1557 Automated Dose Monitoring On Target And Critical Organs Doses For Head And Neck Radiotherapy	23
PO-1585 A fast and robust procedure for independent regular Linac output quantification	23
PO-1603 One more image	23
PD-0804 Therapeutic use of Linac-based SRS in the treatment of malignant spasticity	22
OC-0647 Improved robustness in oesophageal cancer treatment by diaphragm based position verification	22
PD-0788 First results from the national network for quality assurance of MR images in RT in Denmark	22
OC-0109 External validation of a prediction model for two-year mortality in esophageal cancer cohorts	22
OC-0111 Prognostic factors for isolated local recurrence after resection of pancreatic ductal adenocarcinoma	22
PO-1470 Fear is not a Barrier to Radiation Therapy in highly educated members of the public	22
PO-1541 Dosimetric impact of tumour regression in carcinoma cervix treated with radical IMRT	22
PO-1439 Clinical results of SBRT for spinal metastases using dedicated contouring/planning system	22
Radiation therapy for stage IIA/IIB seminomas: Back to the future?	22
PO-1796 Dosimetric comparison of rectal dose reduction methods in brachytherapy for cervical cancer	22
PH-0265 Diaphragm motion prediction based on optical surface with machine learning for liver tumor SBRT	22
OC-0634 Lymphocyte Sparing Radiation Therapy for stage III NSCLC: a dosimetric study	22
PO-1460 Adaptive re-planning with image guided pencil beam scanning proton beam therapy	22

174: Influence of Palliative Radiotherapy on Toxicity and Survival in Patients Treated with Radium-223 Dichloride for Metastatic Castrate-Resistant Prostate Cancer	22
PO-1886 Respiratory motion prediction based on LSTM and linear regression models	22
SP-0016 Dopamine receptor antagonists, radiation, and cholesterol biosynthesis in mouse models of glioblastoma	21
MO-0789 Patient experience of head and neck treatment on a 1.5T MRLinac: is our adaptive solution tolerable?	21
MO-0148 Time trends for online adapative treatment on the 1.5T MR-Linac	21
MO-0725 Radiomics-based prediction of radiosensitivity from preclinical HNSCC histopathology imageS	21
SP-0035 From atlas-based knowledge to ML-based planning solutions	21
MO-0390 Evaluating intra-breath-hold variation in IMAT breast boost patients delivered in DIBH	21
304 the Changing Landscape of Radiation Therapy: Implications for Future Planning	21
12 Safety and Efficacy of Stereotactic Body Radiotherapy for Ultra-Central Thoracic Tumours	21
PO-1835 A glimpse at breast internal mammary chain radiotherapy practice in the United Kingdom	21
MO-0481 Towards near real-time adaptive proton therapy: the partial adaptation strategy	21
SP-0336 Spatially-fractionated radiotherapy: Tumour-subvolumes, dose-delivery and clinical applications	20
PO-2282 SABR Prostate: A review of specialised techniques for motion management	20
PO-1406 Re-irradiation in locally recurrent rectal cancer: a national survey of the AIRO GI study group	20
PO-2353 Impact of Breast volume on Skin toxicities during Hypo-fractionated Radiotherapy in Breast cancer	20
PD-0398 Clinical outcomes of Thyroid Sparing Radical Chemoradiation in the treatment of Head and Neck cancer	20
PD-0418 Interstitial And Surface Mold Brachytherapy For Head And Neck Cancers- An Institutional Experience	20
SP-0356 Low dose radiotherapy reverses resistance to immunotherapy: From bench to bedside	20
PO-1386 Treatment outcomes of 1.5 T MR-guided adaptive radiotherapy for locally advanced pancreatic cancer	20
MO-0804 Determinants of fatigue and longitudinal changes up to 2 years post-radiotherapy for breast cancer	20
PD-0401 The effect of dose to the brain on early self-reported neurocognition; does low dose matter?	20
PO-1779 Detection of mandibular osteoradionecrosis using novel imaging biomarkers for head and neck cancer	20
33 Efficacy of Ultra Hypofrationed Radiotherapy Combined with HDR Brachytherapy	20
247 the Effect of CT Acquisition Parameters on Extracted Radiomic Features Using Computational Phantoms	20
261 A 3D Star Shot to Determine Axes of Rotation	20
PO-1724 Dose-averaged LET may not be the best RBE-descriptor for proton therapy	20
133: Interventions to Support Nutrition in Patients Undergoing Concurrent Chemoradiation for Esophageal Cancer: A Systematic Review of Randomized Trials	20
PD-0733 Parameters influencing inter-Institute variability in KB plan prediction models for whole breast RT	19
PO-1344 Prognostic significance of platelet-to-lymphocyte ratio in hepatocellular carcinoma	19
PD-0230 Correlation between External and Internal Tumour Motion in Lung Stereotactic Ablative Radiotherapy	19
OC-0187 Effects of proton vs photon irradiation on inflammation and senescence in salivary gland organoids	19
OC-0932 Preoperative radiation therapy in early breast cancer: phase II ROCK trial (NCT03520894)	19
PO-2225 Characterization of the RBE of various photon radiation qualities on human cancer cell lines	19
PO-1350 Quality of life changes in esophageal cancer patients treated with preoperative or Radical ChemoRT	19
PD-0240 Development of mid-treatment biological image guided adaptive radiotherapy (BIGART) for glioblastoma	19
OC-0193 Introduction of IMPT for (N)SCLC patients: NTCP model based selection of patients and first results	19
PO-1193 Pattern of practice in elderly patients with HPV positive oropharyngeal cancer: a multicenter study	19
PO-2245 In situ abscopal effect: synergistic efficacy of immunotherapy and partial tumor irradiation	19
206 Sharing Mono-Institutional Experience of Treating Pancreatic Cancer with Stereotactic Body Radiation Therapy (SBRT) as an Adjuvant Therapy for Non-Operative Patients or Salvaging Local Failure	19
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group	19
OC-0282 Inhibition of oxidative phosphorylation alters the tumor microenvironment in syngeneic mouse models	19
OC-0426 ALDH genes as regulators of prostate cancer radioresistance, stemness and bone metastases	18
PO-1893 Gated dynamic trajectory radiotherapy: feasibility, mechanical accuracy and dosimetric validation	18
OC-0441 Risk of cardiac death increases with dose to cardiac sub structure avoidance region in lung cancer	18
OC-0592 Impact of palliative care referral on distress in patients undergoing RT for HNSCC: Randomized Trial	18
126 Investigation of a Monte Carlo Model Based Dose Calculation for 103Pd Low Dose Rate Breast Brachytherapy	18
OC-0432 Patterns of failure in oral cavity squamous cell carcinoma treated with adjuvant radiotherapy	18
PD-0663 Deep learning cycleGAN MRI-only synthetic-CT generation for pelvis, brain and head and neck cancers	18
PO-1131 Proton and carbon ion therapy for intracranial meningioma after previous brain radiotherapy	18
PD-0805 Inter-observer variation for national Danish contouring atlas on organs at risk in the pelvis	18
OC-0594 Head and Neck Squamous Cell Carcinoma derived CAFs alter their phenotype after ionizing radation	18
PO-2130 clinical outcomes of brachytherapy combined with applicator-guided IMRT in bulky cervical tumor	18
OC-0428 Development of DNA polymerase theta inhibitors as tumour specific radiosensitisers	18
PO-2038 Analysis of daily treatment fractions using PerFRACTION on a Halcyon linac	18
PO-1873 Is auto-segmentation in prostate radiotherapy efficient and accurate?	18
SP-0013 Weekly contouring rounds and education movies to improve organ at risk delineation in neuro-oncology	18
PO-1938 Organ motion in thorax and abdomen during radiotherapy: a multicenter study in 188 children	18
PO-1914 Surface Guided Helical Tomotherapy for Total Marrow Irradiation	18
PD-0250 Intrafraction tumor motion monitoring and dose reconstruction for liver spot scanning proton therapy	17
PO-1247 Safety of CDKI combined with radiotherapy in hormone receptor positive breast cancer	17
73: Erectile Function After 60 GY in 20 Fractions External Beam Radiotherapy to the Prostate	17
PO-1685 Creating clinically competitive FLASH proton therapy treatment plans	17
PD-0253 Ultra-compact and highly efficient proton therapy: Design considerations and clinical simulations	17
PO-1708 Application of dose accumulation for PTV margin design in MR-guided adaptive prostate SBRT	17
PD-0962 Second PFS after post-PACIFIC relapse in the Blue Sky observational study on stage 3 NSCLC.	17
PO-2166 Commissioning of new rectal applicator using electronic brachytherapy source	17
PO-1674 Going from planar kV-MV to kV-kV setup images in image-guided radiotherapy of breast cancer	17
PD-0248 Can surface imaging predict the impact of anatomical deformations on proton breast treatment?	17
MO-0721 Clinicogenomic predictors for the pattern of failure in high-grade glioma	17
SP-0197 Status of brachytherapy education for brachytherapists and future needs in North America	17
PO-1964 Towards a novel treatment plan evaluation concept in carbon ion radiotherapy based on high-LET-dose	17
PD-0231 Acute toxicity after the 5-fraction versus 15-fraction radiotherapy regimen for early breast cancer	17
PD-0654 Surface Guided Radiotherapy accuracy vs tattoos position in 5- fractions breast radiotherapy.	17
PO-1694 MRI derived brain morphometric measurements: effect of voxel size, anisotropy and slice orientation	17
PO-1281 External validation of the MSKCC nomogram for Ductal Carcinoma in Situ and risk factors analysis	17
109: Prostate Cancer-Specific Death Rates in Localized Prostate Cancer: Data from Two Randomized Trials	17
OC-0603 PEACE V – STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity	17
PO-1468 LATTICE radiotherapy: A one institution experience	16
SP-1007 For the motion	16
SP-1017 Proton arc therapy: Rationale and current status	16
PO-1640 MRI-based deep learning autocontouring: Evaluation and implementation for brain radiotherapy	16
PO-1279 68Gy EQD2 Constraint For G2-Vaginal Shortening In Post-Operative Endometrium. Preliminary Results.	16
MO-0881 Evaluation of plan-of-the-day selection in adaptive radiation therapy of cervical cancer	16
MO-0951 Outcome of total body irradiation for hematopoietic stem cell transplantation conditioning	16
PO-1325 Automated rectal tumor segmentation with inter-observer variability-based uncertainty estimates	16
Response to comment on “Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC”	16
PO-1251 Perceived-health status in lung cancer survivors presenting long-term radiotherapy-related fatigue.	16
PO-1294 Timing to assess the clinical response after chemoradiotherapy in locally advanced cervical cancer	16
OC-0623 First-in-human clinical translation of oxygen-enhanced MRI onto an MR Linac	16
20: Machine Learning Classifier to Reproduce Lung Metastases Tumour Board Decisions	16
PO-1632 deep learning-based automatic segmentation of rectal tumors in endoscopy images	16
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer	16
SP-1017 What have we learnt and translation to the clinic?	16
PO-1423 PSA dynamics forecasts identify tumor recurrence after external radiotherapy for prostate cancer	16